Myelomeningocele - a single institute analysis of the years 2007 to 2015

Elke Januschek1,2, Andreas Röhrig3, Sandra Kunze3

  • 1Neurosurgical Department, Sana Klinikum Offenbach GmbH, Starkenburgring 66, 63069, Offenbach, Germany. e.januschek@gmx.de.

Insights

Myelomeningocele (MMC) treatment in newborns shows high rates of associated Chiari II malformations and hydrocephalus. An interdisciplinary approach facilitated independence and social continence in most patients.

Area of Science:

  • Pediatric Neurosurgery
  • Developmental Neurology
  • Congenital Malformations

Background:

  • Folate supplementation has decreased open spinal dysraphism rates.
  • A dedicated pediatric neurosurgery department was established in 2007.
  • Myelomeningocele (MMC), a common open neural tube defect (NTD), is treated in newborns at this institution.

Purpose of the Study:

  • To present the treatment concepts and outcomes for myelomeningocele (MMC) in newborns.
  • To analyze surgical interventions and associated comorbidities in pediatric spinal dysraphism cases.

Main Methods:

  • Retrospective analysis of surgical records for newborns with MMC from January 2007 to August 2015.
  • Exclusion of infants with prior in utero surgery.
  • Data collection on NTD type, location, comorbidities, and ambulation.

Main Results:

  • 48 infants with spinal dysraphism were analyzed; 90% underwent MMC repair on the day of delivery.
  • Associated conditions included Chiari malformation type II (75%) and hydrocephalus (85.4%), requiring shunt implantation.
  • 70% of patients were ambulatory (with or without orthoses/devices); 83.3% with bladder impairment managed with intermittent catheterization.

Conclusions:

  • Neural tube defects can remain undetected during pregnancy despite prenatal care.
  • Chiari II malformations and hydrocephalus are common comorbidities with MMC.
  • An interdisciplinary approach promotes independence and social continence in MMC patients.
Abstract

Related Concept Videos